Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1976-06-30
1977-06-28
Hunt, Brooks H.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
424 12, 23230B, 232306, G01N 3300, A61K 3900
Patent
active
040326268
ABSTRACT:
The concentration of thyroxine binding globulin (TBG) in a fluid sample can be determined via radioassay technique with an immunochemical composite comprising anti-TBG antibodies immobilized on a water-insoluble carrier. The composite is incubated with the sample in a quantity sufficient to assure complexation of substantially all TBG in the sample to the antibodies of the composite. The quantity of TBG complexed is determined with radiolabeled thyroxine (T.sub.4) which complexes with at least a portion of the complexed TBG. By separating the labeled composite from the remaining labeled T.sub.4, and counting the bound (or unbound) T.sub.4, the concentration of TBG can be determined from a standard curve.
REFERENCES:
patent: 3933997 (1976-01-01), Hersh et al.
patent: 3960492 (1976-06-01), DiGiulio
patent: 3975511 (1976-08-01), Vann et al.
Corning Glass Works
Giblin James A.
Hunt Brooks H.
Janes Jr. Clinton S.
Nucker Christine M.
LandOfFree
Reagent and method for TBG assay does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Reagent and method for TBG assay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reagent and method for TBG assay will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1521814